ArticleFrontiers in immunology2025

Case Report: Exploring delayed hyperprogressive disease: a case study of post-immunotherapy in lung cancer.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.